Foreign investors have sold over Rs 2.23 lakh crore in 2025, yet domestic institutions and SIP flows have absorbed the shock. Despite heavy FII selling, Indian equity markets remain resilient, supported by consistent retail participation and strong earnings prospects.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,